Skip to main content
Charles Hemenway, MD, Pediatric Hematology & Oncology, Maywood, IL, Children's Hospital

CharlesSHemenwayMD

Pediatric Hematology & Oncology Maywood, IL

Professor, Pediatrics, Loyola University Chicago Stritch School of Medicine

Dr. Hemenway is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hemenway's full profile

Already have an account?

Summary

  • Dr. Charles Hemenway is a pediatric hematologist/oncologist in Maywood, IL. He received his medical degree from University of Massachusetts Medical School and has been in practice 30 years. He is experienced in general hematologic and oncologic diseases in children. His research focus is fusion oncogene proteins in childhood leukemia.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1991 - 1995
  • University of Florida College of Medicine
    University of Florida College of MedicineResidency, Internal Medicine/Pediatrics, 1987 - 1991
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 1987

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 2022 - 2024
  • IL State Medical License
    IL State Medical License 2007 - 2023
  • NC State Medical License
    NC State Medical License 1995 - 1998
  • FL State Medical License
    FL State Medical License 1989 - 1994
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Press Mentions

  • Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer Doctors
    Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019

Grant Support

  • Structure/Function Of AF9 And MLL-AF9National Cancer Institute2011
  • Targeted Therapy For 11Q23 Acute LeukemiasNational Cancer Institute2009–2011
  • Disrupting The AF4-AF9 Protein Complex In MLL Leukemias.National Cancer Institute2008–2009
  • Tulane Cancer Genetics Cobre: Inovative Therapies For T(4;11) LeukemiaNational Center For Research Resources2004–2008
  • Targeted Therapy For 11Q23 Acute Leukemias.National Cancer Institute2004–2007
  • BMI1 Interacting Proteins In Neoplastic TransformationNational Cancer Institute1999–2002

Professional Memberships

Hospital Affiliations